FNCH Finch Therapeutics Group Inc

Titoli in rialzo Le azioni di Kineta (NASDAQ:KA) hanno guadagnato l'11,21% a 0,60 dollari durante la sessione after-market di luned . Le azioni di Finch Therapeutics Gr (NASDAQ:FNCH) sono salite...

AIM ImmunoTech (NYSE:AIM - Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the...

Finch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Free Report) Director Jeffery A. Smisek sold 6,642 shares of the company's stock in a transaction that occurred on Thursday, March 28th. The shares...